QIAGENES
DEAD

Serial Number

85054974

Owner

QIAGEN GMBH

Attorney

David G. Rosenbaum

Filing Date

Jun 4, 2010

Add to watchlist:

No watchlists yet
View on USPTO

QIAGENES Trademark

Serial Number: 85054974 • Registration: 4100901

QIAGENES is a trademark filed by QIAGEN GMBH on June 4, 2010. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently no longer active.

Owner Contact Info

QIAGEN GMBH (212 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

June 4, 2010

Registration Date

February 21, 2012

Published for Opposition

December 6, 2011

Cancellation Date

September 28, 2018

Goods & Services

Scientific apparatuses, instruments and equipment, namely, optical apparatuses and instruments, namely, optical emission spectrometers, atomic absorption spectrometers, X-ray machines other than for medical use, optical inspection apparatuses for industrial use; chemical detection system comprising strobe and probe lasers, and optical detectors; calculating machines, electrical and electronic apparatuses and instruments, namely, computer-controlled electronic measuring machines for electrophysiological measurements and testing of cells and fluid samples, in particular for research and analysis purposes, and laboratory equipment, namely, chromatography apparatuses for laboratory use; laboratory instruments, namely, laboratory robot manipulators designed to move, handle, and facilitate the processing of samples; measuring apparatus and laboratory equipment, namely, laboratory consumable dispensers, namely, pipettes for the transfer of liquids, live cells, and fluid samples, laboratory sample conditioners, namely, incubators, stirrers for stirring fluids, solutions, and fluid samples, mixers for stirring fluids, dispensers for the transfer of fluids, live cells, and fluid samples, aspirators for fluids and fluid samples, ultrafiltration devices for detection, concentration, separation, and purification of biological samples, ultrafiltration filters for filtration of biological samples, chromatography apparatuses and instruments for laboratory use, automatic ion exchange chromatography apparatuses for laboratory use

Products for human medicine and veterinary medicine purposes, namely, diagnostic preparations for medical diagnostic use, in particular for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological products all for human medicine and veterinary medicine purposes, namely, reagents and solvents for medical diagnostic use, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits for medical diagnostic use consisting primarily of protein assays and chemical reagents for human medicine or veterinary medicine diagnostic purposes, in particular for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological material

Diagnostic preparations, except for human medicine and veterinary medicine purposes; reagents and solvents for research and not for human medical and veterinary purposes, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits consisting primarily of protein assays and chemical reagents for research, in particular for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological material

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 28, 2018 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 21, 2017 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 10, 2015 TCCA
REGISTERED-PRINCIPAL REGISTER
Feb 21, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 6, 2011 NPUB
PUBLISHED FOR OPPOSITION
Dec 6, 2011 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 16, 2011 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 31, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 19, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 2011 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 18, 2011 ERFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 18, 2011 TCCA
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 10, 2011 GNFN
FINAL REFUSAL E-MAILED
Aug 10, 2011 GNFR
FINAL REFUSAL WRITTEN
Aug 10, 2011 CNFR
DATA MODIFICATION COMPLETED
Aug 5, 2011 DMCC
ASSIGNED TO LIE
Aug 5, 2011 ALIE
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2011 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 21, 2011 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 18, 2011 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 18, 2011 GNSL
SUSPENSION LETTER WRITTEN
Mar 18, 2011 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 17, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 16, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 16, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 16, 2010 GNRN
NON-FINAL ACTION E-MAILED
Sep 16, 2010 GNRT
NON-FINAL ACTION WRITTEN
Sep 16, 2010 CNRT
ASSIGNED TO EXAMINER
Sep 15, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2010 NWOS
NEW APPLICATION ENTERED
Jun 8, 2010 NWAP